Lv2
110 积分 2025-04-21 加入
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
27天前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
28天前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
28天前
已完结
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
1个月前
已完结
Multidrug-resistant Gram-negative bacterial infections
2个月前
已完结
外科常见腹腔感染多学科诊治专家共识
2个月前
已完结
Pre- and postantibiotic epoch: The historical spread of antimicrobial resistance
2个月前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
2个月前
已完结
Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery
3个月前
已完结
多模态模型应用于腹腔感染诊断与预警的应用前景
3个月前
已关闭
皖公网安备34019202002308
